Moritaka Goto Selected Research

Carcinogenesis

1/2020

Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moritaka Goto Research Topics

Disease

5	Insulin Resistance 03/2020 - 07/2013
3	Secondary Hyperparathyroidism 10/2023 - 10/2022
3	Hyperplasia 01/2023 - 02/2002
3	Obesity 03/2020 - 12/2016
3	Body Weight (Weight, Body) 01/2020 - 07/2013
3	Hyperglycemia 12/2016 - 07/2002
2	Hypocalcemia 10/2023 - 01/2023
2	Fibrosis (Cirrhosis) 01/2023 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 11/2016 - 07/2013
2	Glucose Intolerance 07/2013 - 05/2007
2	Ischemia 10/2003 - 06/2002
1	Chronic Renal Insufficiency 10/2023
1	Renal Insufficiency (Renal Failure) 01/2023
1	Vascular Calcification 01/2023
1	Carcinogenesis 01/2020
1	Inflammation (Inflammations) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2019
1	Neoplasms (Cancer) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Hypercholesterolemia 11/2018
1	Diabetes Mellitus 12/2016
1	Atherosclerosis 01/2016
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 07/2002

Drug/Important Bio-Agent (IBA)

6	anagliptinIBA 01/2020 - 07/2013
5	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019 - 07/2013
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2007
3	upacicalcetIBA 10/2023 - 10/2022
3	Nitric Oxide Synthase (NO Synthase)IBA 10/2003 - 02/2002
3	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 10/2003 - 02/2002
3	Arginine (L-Arginine)FDA Link 10/2003 - 02/2002
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2003 - 02/2002
2	Calcium-Sensing ReceptorsIBA 10/2023 - 01/2023
2	CalciumIBA 01/2023 - 10/2022
2	miglitol (Glyset)FDA Link 03/2020 - 12/2016
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2019 - 11/2016
2	CholesterolIBA 11/2018 - 01/2016
2	Insulin (Novolin)FDA Link 01/2017 - 11/2016
2	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 10/2003 - 06/2002
2	AlloxanIBA 02/2003 - 07/2002
2	Carbachol (Carbastat)FDA Link 07/2002 - 06/2002
2	N(G),N(G')-dimethylarginineIBA 06/2002 - 02/2002
1	Peptides (Polypeptides)IBA 10/2023
1	NitrogenIBA 01/2023
1	Urea (Carbamide)FDA LinkGeneric 01/2023
1	Adenine FDA LinkGeneric 01/2023
1	CreatinineIBA 01/2023
1	Phosphorus (Red Phosphorus)IBA 01/2023
1	Amino Acids FDA Link 10/2022
1	Glycoside Hydrolase InhibitorsIBA 03/2020
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Insulin Receptor Substrate ProteinsIBA 01/2017
1	Sodium-Glucose Transport ProteinsIBA 01/2017
1	LeptinIBA 12/2016
1	GlucosidasesIBA 12/2016
1	Metformin (Glucophage)FDA LinkGeneric 12/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2016
1	IncretinsIBA 11/2016
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2016
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	GlucokinaseIBA 07/2013
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 10/2003
1	symmetric dimethylarginineIBA 10/2003
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 10/2003
1	fidarestatIBA 02/2003
1	Sorbitol (Yal)FDA Link 02/2003
1	polyolIBA 02/2003
1	Aldehyde Reductase (Aldose Reductase)IBA 02/2003
1	Adenosine Triphosphate (ATP)IBA 07/2002
1	Cholinergic Agents (Cholinergics)IBA 07/2002
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 07/2002
1	Serotonin (5 Hydroxytryptamine)IBA 07/2002
1	NucleotidesIBA 02/2002
1	Endothelin-1 (Endothelin 1)IBA 02/2002

Therapy/Procedure

1	Cell Transplantation 11/2019
1	Therapeutics 12/2016
1	Glycemic Control 12/2016
1	Intravenous Injections 07/2002